A Medicare watchdog report concludes that buprenorphine is rarely misused and is an important tool to address the nation’s opioid crisis.
Author: Ken Alltucker, USA TODAY
How the US reports COVID data is about to change. Here’s what you need to know.
As the public health emergency ends May 11, the CDC will change how it reports COVID data and will no longer be counting every case.
Eli Lilly says new Alzheimer’s drug donanemab slows early stages of disease by 35%
Lilly said people on the drug donanemab slowed decline by 35% based on a measure of daily activities such as driving and talking about current events.
US faces ‘perfect storm’ nurse staffing crisis: About a third plan to leave, survey finds
Two reports show how nurses perceive their profession amid a staffing crisis, growing workloads and stressed hospitals.
A new COVID variant called Arcturus is linked to pink eye. Here’s what you need to know.
The XBB.1.16 strain of omicron, known as Arcturus, has been linked to pink eye and fever. Here’s what to know about symptoms and treatment.
Cease-fire in Sudan extended three days, Secretary of State Antony Blinken says: Live updates
The U.S. has deployed intelligence, surveillance and reconnaissance assets to aid people traveling by land from Khartoum to the Port of Sudan.
As states cut Medicaid, some fear they’ll mistakenly end coverage for millions of eligible people
States are resuming Medicaid eligibility checks that were paused during the COVID public health emergency.
Animal ‘tranq’ xylazine is becoming a deadly threat. Here’s how the US is trying to stop it.
Biden’s drug czar Dr. Rahul Gupta announces plans to stop the spread of deadly xylazine, a veterinary tranquilizer mixed with fentanyl.
How xylazine – a tranquilizer showing up in fentanyl – makes it harder to slow overdose deaths
Xylazine, known as the street drug tranq or zombie heroin, is increasingly being found in fentanyl and heroin. It’s known to cause open wounds.
FDA approves overdose-reversing drug Narcan for over-the-counter sales
The FDA approved selling naloxone over-the-counter, marking the first time an opioid treatment drug will be available without prescription.